This work may not be copied, distributed, displayed, published, reproduced, transmitted, modified, posted, sold, licensed, or used for commercial purposes. By downloading this file, you are agreeing to the publisher’s Terms & Conditions.

Letters to the Editor

Risperidone Monotherapy for Psychotic Depression Unresponsive to Other Treatments

Hsien-Yuan Lane and Wen-Ho Chang

Published: November 15, 1998

Article Abstract

Sir: Risperidone, an atypical antipsychotic agent, has been reported to yield acute antidepressant effects in certain patients with schizophrenia, schizoaffective disorder, or psychotic depression. Furthermore, it has been demonstrated that adding risperidone to preexisting antidepressants can improve chronic depression. However, it remains unclear whether risperidone alone is effective in treating psychotic depression resistant to other treatments; earlier reports concerning risperidone monotherapy for psychotic depression did not reveal subjects’ previous treatment responses.

Some JCP and PCC articles are available in PDF format only. Please click the PDF link at the top of this page to access the full text.

Related Articles

Volume: 59

Quick Links: Psychotic Disorders , Schizophrenia and Schizoaffective Disorders


Sign-up to stay
up-to-date today!


Already registered? Sign In

Original Research

Sublingual Dexmedetomidine for the Treatment of Acute Agitation in Adults With Schizophrenia or Schizoaffective Disorder: A Randomized Placebo-Controlled Trial

This RCT determined whether a single dose of sublingual dexmedetomidine reduced acute agitation associated with schizophrenia or...